CREO — Creo Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £127.34m
- £110.04m
- £27.17m
- 44
- 16
- 63
- 32
Annual cashflow statement for Creo Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 18 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.8 | -15.9 | -20.3 | -24.6 | -26.9 |
| Depreciation | |||||
| Non-Cash Items | -1.06 | -1.41 | -2.3 | -2.65 | -2.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.07 | 4.83 | 4.74 | -1.33 | 1.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.3 | -11.9 | -16.3 | -26 | -25.1 |
| Capital Expenditures | -1.39 | -1.12 | -0.576 | -6.12 | -3.27 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.104 | 0.311 | -20.4 | -1.72 | -2.69 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.28 | -0.807 | -21 | -7.84 | -5.96 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 46.5 | 49.1 | 1.33 | 32 | 0.522 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 30.9 | 36.5 | -36 | -1.56 | -30.4 |